Shares of Guardant Health Inc. (GH) fell sharply by 5.11% in the pre-market session on Friday, as the company reported disappointing financial results for the quarter ended December 31, 2024.
According to the earnings report, Guardant Health posted an adjusted loss of $0.90 per share, missing analysts' expectations of a loss of $0.74 per share. The company's revenue grew 30.2% year-over-year to $201.81 million, but still fell short of the consensus estimate of $192.14 million.
The disappointing earnings performance and failure to meet Wall Street's estimates appear to have triggered the sharp sell-off in Guardant Health's stock. Investors may have concerns about the company's profitability and growth prospects, as it continues to report significant losses despite revenue growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.